160 related articles for article (PubMed ID: 11587401)
1. Intravenous vancomycin pharmacokinetics in automated peritoneal dialysis patients.
Manley HJ; Bailie GR; Frye RF; McGoldrick MD
Perit Dial Int; 2001; 21(4):378-85. PubMed ID: 11587401
[TBL] [Abstract][Full Text] [Related]
2. Intermittent intravenous piperacillin pharmacokinetics in automated peritoneal dialysis patients.
Manley HJ; Bailie GR; Frye R; McGoldrick MD
Perit Dial Int; 2000; 20(6):686-93. PubMed ID: 11216560
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.
Manley HJ; Bailie GR; Frye R; Hess LD; McGoldrick MD
J Am Soc Nephrol; 2000 Jul; 11(7):1310-1316. PubMed ID: 10864588
[TBL] [Abstract][Full Text] [Related]
4. Small and middle molecular weight solute clearance in nocturnal intermittent peritoneal dialysis.
Brophy DF; Sowinski KM; Kraus MA; Moe SM; Klaunig JE; Mueller BA
Perit Dial Int; 1999; 19(6):534-9. PubMed ID: 10641773
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic profiles of ceftazidime after intravenous administration in patients undergoing automated peritoneal dialysis.
Kim K; Hwang YH; Ro H; Oh YK; Kim MG; Yu KS; Shin KH; Jang IJ; Shin SG; Ahn C; Oh KH
Antimicrob Agents Chemother; 2011 Jun; 55(6):2523-7. PubMed ID: 21402833
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the pharmacodynamic profile of commonly used intravenous vancomycin dosing schemes in patients on automated peritoneal dialysis.
Cardone KE; Chen WZ; Grabe DW; Batzold A; Manley HJ; Lodise TP
J Antimicrob Chemother; 2014 Jul; 69(7):1873-6. PubMed ID: 24722842
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin disposition following intraperitoneal administration in children receiving peritoneal dialysis.
Blowey DL; Warady BA; Abdel-Rahman S; Frye RF; Manley HJ
Perit Dial Int; 2007; 27(1):79-85. PubMed ID: 17179516
[TBL] [Abstract][Full Text] [Related]
8. Short-Dwell Cycling Intraperitoneal Cefazolin Plus Ceftazidime in Peritoneal Dialysis Patients.
Peerapornratana S; Chariyavilaskul P; Kanjanabuch T; Praditpornsilpa K; Eiam-Ong S; Katavetin P
Perit Dial Int; 2017; 37(2):218-224. PubMed ID: 27738089
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal pharmacokinetics of vancomycin in patients on automated peritoneal dialysis.
Lam E; Ting Kayla Lien Y; Kraft WK; Stickle DF; Piraino B; Zhang J
Clin Transl Sci; 2022 Mar; 15(3):649-657. PubMed ID: 34755479
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intraperitoneal cefepime in automated peritoneal dialysis.
Elwell RJ; Frye RF; Bailie GR
Perit Dial Int; 2005; 25(4):380-6. PubMed ID: 16022096
[TBL] [Abstract][Full Text] [Related]
11. Treatment of peritonitis in APD: pharmacokinetic principles.
Manley HJ; Bailie GR
Semin Dial; 2002; 15(6):418-21. PubMed ID: 12437537
[TBL] [Abstract][Full Text] [Related]
12. Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.
Neal D; Bailie GR
Clin Pharmacokinet; 1990 Jun; 18(6):485-90. PubMed ID: 2354591
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
Manley HJ; Bailie GR; Asher RD; Eisele G; Frye RF
Perit Dial Int; 1999; 19(1):65-70. PubMed ID: 10201343
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of Intraperitoneal Cefalothin and Cefazolin in Patients Being Treated for Peritoneal Dialysis-Associated Peritonitis.
Roberts DM; Ranganathan D; Wallis SC; Varghese JM; Kark A; Lipman J; Roberts JA
Perit Dial Int; 2016; 36(4):415-20. PubMed ID: 26764340
[TBL] [Abstract][Full Text] [Related]
16. Body surface area limitations in achieving adequate therapy in peritoneal dialysis patients.
Rocco MV
Perit Dial Int; 1996; 16(6):617-22. PubMed ID: 8981531
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin and ciprofloxacin: systemic antibiotic administration for peritoneal dialysis-associated peritonitis.
Goffin E; Herbiet L; Pouthier D; Pochet JM; Lafontaine JJ; Christophe JL; Gigi J; Vandercam B
Perit Dial Int; 2004; 24(5):433-9. PubMed ID: 15490982
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy.
Lam E; Lien YTK; Kraft WK; Piraino B; Vozmediano V; Schmidt S; Zhang J
Perit Dial Int; 2020 Jul; 40(4):384-393. PubMed ID: 32065053
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of once daily intra-peritoneal aztreonam and vancomycin in the treatment of CAPD peritonitis.
Brown J; Altmann P; Cunningham J; Shaw E; Marsh F
J Antimicrob Chemother; 1990 Jan; 25(1):141-7. PubMed ID: 2318749
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
